effective and safe results
Neither medication currently has a generic version available
Nausea is the most common side effect during titration and is mitigated by slow up-titration plus PRN ondansetron when needed
32,33 In addition, the AMS prevalence is positively correlated with the rate of ascent
Loos, a professor at the University of Copenhagen and affiliated with a research center supported by the Novo Nordisk Foundation (the maker of Wegovy and Ozempic), noted, "The current model explains only 25% of the variability, and further research is needed to uncover the remaining 75%." However, she also expressed optimism, stating, "By combining genetic and clinical information, the era of personalized medicine, where we can select the best drug for each patient, may be upon us."